Tags

Type your tag names separated by a space and hit enter

[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology].
Dtsch Med Wochenschr. 2021 Jul; 146(13-14):899-903.DM

Abstract

Infection with SARS-CoV-2 has a profound influence on the hematopoetic system that mediates clinical symptoms and mortality. Several studies have shown that treatment of the cytokine storm (CRS) with anti-inflammatory drugs like dexamethasone and tocilizumab can significantly improve survival. Systematic reviews confirm the safety of convalescent plasma administration and offer initial indications of its effectiveness in certain groups. COVID-associated coagulopathy (CAC) and vaccine-induced immune thrombotic thrombocytopenia (VITT) represent severe infection- or vaccination associated complications that require a specific diagnostic and therapeutic workup.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

ger

PubMed ID

34256404

Citation

Spiekermann, Karsten, et al. "[Update 2021: COVID-19 From the Perspective of Haematology and Haemostaseology]." Deutsche Medizinische Wochenschrift (1946), vol. 146, no. 13-14, 2021, pp. 899-903.
Spiekermann K, Subklewe M, Hildebrandt M, et al. [Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]. Dtsch Med Wochenschr. 2021;146(13-14):899-903.
Spiekermann, K., Subklewe, M., Hildebrandt, M., Humpe, A., & von Bergwelt-Baildon, M. (2021). [Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]. Deutsche Medizinische Wochenschrift (1946), 146(13-14), 899-903. https://doi.org/10.1055/a-1449-4934
Spiekermann K, et al. [Update 2021: COVID-19 From the Perspective of Haematology and Haemostaseology]. Dtsch Med Wochenschr. 2021;146(13-14):899-903. PubMed PMID: 34256404.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]. AU - Spiekermann,Karsten, AU - Subklewe,Marion, AU - Hildebrandt,Martin, AU - Humpe,Andreas, AU - von Bergwelt-Baildon,Michael, Y1 - 2021/07/13/ PY - 2021/7/13/entrez PY - 2021/7/14/pubmed PY - 2021/7/21/medline SP - 899 EP - 903 JF - Deutsche medizinische Wochenschrift (1946) JO - Dtsch Med Wochenschr VL - 146 IS - 13-14 N2 - Infection with SARS-CoV-2 has a profound influence on the hematopoetic system that mediates clinical symptoms and mortality. Several studies have shown that treatment of the cytokine storm (CRS) with anti-inflammatory drugs like dexamethasone and tocilizumab can significantly improve survival. Systematic reviews confirm the safety of convalescent plasma administration and offer initial indications of its effectiveness in certain groups. COVID-associated coagulopathy (CAC) and vaccine-induced immune thrombotic thrombocytopenia (VITT) represent severe infection- or vaccination associated complications that require a specific diagnostic and therapeutic workup. SN - 1439-4413 UR - https://www.unboundmedicine.com/medline/citation/34256404/[Update_2021:_COVID-19_from_the_Perspective_of_Haematology_and_Haemostaseology]. L2 - https://www.thieme-connect.com/DOI/DOI?10.1055/a-1449-4934 DB - PRIME DP - Unbound Medicine ER -